Evidence map›Paper›PMID 40254669›Full record

ArticleAnalytical sciences : the international journal of the Japan Society for Analytical Chemistry2025

Ultra-sensitive biosensor detection of microRNA based on the CRISPR/Cas12a system and exonuclease-assisted target recycling signal amplification.

Xing Yang, Yu Luo, Chunhua Su, Zhimei Huang, Yafang Tang, Liwen Zhang

Abstract read
PubMed Publisher
In one paragraph

Article in Analytical sciences : the international journal of the Japan Society for Analytical Chemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Xing YangClinical Research Center for Neurological Diseases of Guangxi Province, Affiliated Hospital of Guilin Medical University, Guilin, 541004, China.
Yu LuoClinical Research Center for Neurological Diseases of Guangxi Province, Affiliated Hospital of Guilin Medical University, Guilin, 541004, China.
Chunhua SuDepartment of Cardiovascular Medicine, Second Affiliated Hospital of Guilin Medical University, Guilin, 541100, China.
Zhimei HuangClinical Research Center for Neurological Diseases of Guangxi Province, Affiliated Hospital of Guilin Medical University, Guilin, 541004, China.
Yafang TangClinical Research Center for Neurological Diseases of Guangxi Province, Affiliated Hospital of Guilin Medical University, Guilin, 541004, China. tangavonrs@163.com.
Liwen ZhangInformation Center, Guilin Medical University, Guilin, 541199, Guangxi, China. zlw@glmc.edu.cn.ORCID http://orcid.org/0009-0000-4803-7724

Funding

Autonomous region health commission self-funded research project Z-C20240897Middle-aged and Young Teachers' Basic Ability Promotion Project of Guangxi 2022KY0491Natural Science Foundation of Guangxi Zhuang Autonomous Region 2021GXNSFBA 076001
6 · The paper itself

Abstract

MicroRNAs (miRNAs) are essential regulators of gene expression and are significantly involved in both preventing and treating a range of diseases. To that end, we developed an ultra-sensitive detection method for miRNA-141 by integrating exonuclease-assisted target recycling signal amplification with the CRISPR/Cas12a system. This method employs a variable hairpin probe (HP) designed to hybridize with miRNA, which, under the action of exonuclease III (ExoIII), cleaves the hairpin probe and triggers target recycling signal amplification. This results in the formation of output DNAs (ODs) containing multiple repeat sequences. The CRISPR/Cas12a system identifies these repeated sequences in ODs through its crRNA component, which in turn triggers the trans-cleavage function of the Cas12a/crRNA complex. It leads to the cleavage of a fluorescently quenched reporter probe. Consequently, this process restores fluorescence, producing a significantly enhanced fluorescent signal that facilitates the detection of miRNA-141, achieving a detection threshold down to 62 fM. This detection approach can specifically differentiate miRNA-141 from other confounding substances and has effectively identified low concentrations of miRNA-141 in actual sample human serum and diverse cancer cell lysates, showcasing its capability for tracing various nucleic acid biomarkers at minimal levels.

Indexed as

Biosensing TechniquesCRISPR-Cas SystemsExodeoxyribonucleasesExonucleasesMicroRNAsNucleic Acid Amplification TechniquesBacterial ProteinsCRISPR-Associated ProteinsEndodeoxyribonucleasesHumansLimit of DetectionBacterial ProteinsCas12a proteinCRISPR-Associated ProteinsEndodeoxyribonucleasesexodeoxyribonuclease IIIExodeoxyribonucleasesExonucleasesMicroRNAsMIRN141 microRNA, humanCRISPR/Cas12aExoIIIMiRNA-141Target recycling signal amplification

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.